Anlon Healthcare Limited has successfully secured shareholder approval for its strategic shift in IPO fund utilization, with an overwhelming majority voting in favor of reallocating ₹2,332.69 lakhs from capital expenditure to strategic acquisitions. The postal ballot concluded on January 7, 2026, marking a significant milestone in the company's growth strategy.

Voting Results Overview

The postal ballot results demonstrate strong shareholder confidence in the company's strategic direction:

Strategic Fund Reallocation Details

The approved resolution allows Anlon Healthcare to redirect funds originally planned for greenfield expansion towards strategic acquisitions:

Postal Ballot Process

The voting process was conducted entirely through electronic means, with Mr. Keyur Ghelani of M/s. K. P. Ghelani and Associates serving as the scrutinizer. The e-voting facility was provided by Kfin Technologies Limited, ensuring transparency and compliance with regulatory requirements.

Strategic Benefits

The approved strategy shift from greenfield to brownfield investment offers several advantages:

• Immediate Capacity Addition: Access to validated production lines and established systems
• Time Efficiency: Avoiding longer timelines associated with new facility construction
• Early Revenue Generation: Faster monetization of acquired assets
• Operational Synergies: Leveraging existing regulatory approvals and trained workforce

Financial Impact

The reallocation represents a significant portion of the company's IPO proceeds:

With this overwhelming shareholder approval, Anlon Healthcare can now proceed with its planned acquisitions of Bizotic Lifescience Private Limited and Apiqo Organics Private Limited, positioning the company for accelerated growth through strategic inorganic expansion.

Anlon Healthcare Limited has announced plans to establish a new marketing office in Ahmedabad, Gujarat, marking a significant step in the company's expansion strategy. The announcement was made through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Business Expansion Details

Anlon Healthcare Limited disclosed its intention to open the marketing office in Ahmedabad in the near future, though specific timelines were not provided in the announcement. This expansion move appears to be part of the company's strategy to strengthen its market presence in the Gujarat region.

Regulatory Compliance

The disclosure was made in compliance with the listing regulations, demonstrating Anlon Healthcare's commitment to maintaining transparency with stakeholders and regulatory authorities. The company has assured that it will provide further updates as developments progress regarding this new facility.

Company Background

Anlon Healthcare Limited operates in the chemicals sector and is registered in Gujarat. The company's registered office is located at 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat. Anlon Healthcare maintains its commitment to keeping stakeholders informed about significant business developments through proper regulatory channels.

The establishment of a marketing office in Ahmedabad represents the company's strategic focus on expanding its operational footprint within Gujarat, potentially enhancing its market reach and customer engagement capabilities in the region.